G
Gregory R. Naumiec Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Associate Professor
faculty
6 h-index
11 pubs
223 cited
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Gregory R. Naumiec's research focuses on the synthesis and evaluation of novel chemical compounds for therapeutic applications. His work has explored disquaramide compounds as a promising class of anti-leishmanial drugs, as indicated by a 2024 publication. Naumiec's scholarship metrics include an h-index of 6, with 11 total publications and 222 citations. He has collaborated with researchers from the University of Arkansas for Medical Sciences, including Alexx Weaver, Hayden Roys, Anne K. Bowlin, and Lucy Fry, with whom he shares one publication each. Naumiec is an Associate Professor at the University of Central Arkansas.
Metrics
- h-index: 6
- Publications: 11
- Citations: 223
Selected Publications
-
Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs (2024)
Collaboration Network
Top Collaborators
Hayden Roys
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Assyl Arykbayeva
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Sarah K. Friedman
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Gabriel Gifford
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Eva R. Palmer
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Alex Rogers
University of Central Arkansas (US)
1 shared publication
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Emily N. H. Tran
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Lucy Fry
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Alexx Weaver
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Anne K. Bowlin
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Meghan D. Jones
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Michael R. Eledge
University of Arkansas for Medical Sciences (US)
1 shared publication
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Karl W. Boehme
University of Arkansas for Medical Sciences (US)
1 shared publication
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Tiffany Weinkopff
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Similar Researchers
Based on overlapping research topics
Benjamin Rougeau
Arkansas State University
Synthesis and biological activity
Microbial infections and disease research
Drug Delivery Systems
Hannah Wu
University of Arkansas for Medical Sciences
Microbial infections and disease research
Pharmacological Effects and Toxicity Studies
Metabolism and Genetic Disorders
Jacob M Kaufman
University of Arkansas at Fayetteville
Microbial infections and disease research
Pharmacological Effects and Toxicity Studies
Metabolism and Genetic Disorders
Md. Abdul Hye Khan
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Drug Delivery Systems
Metabolism and Genetic Disorders
David F. Gilmore
Arkansas State University
Synthesis and biological activity
Microbial infections and disease research
Pharmacological Effects and Toxicity Studies
Raj KC. Hansa
Arkansas State University
Synthesis and biological activity
Microbial infections and disease research
Pharmacological Effects and Toxicity Studies